Why IMU is a multi multi bagger, page-24525

I still believe in science behind the IMU and all subject matter excerpts, however the primary issue with IMU is strategic differentiation from others. There are several Pharma companies in ASX (list below with few missing like ALA) trying to address cure for cancers and only few are at treatment and diagnostic stage, however IMU has strategical differentiation from others in respect that it is trying to address unmet need to all cancers rather than focusing in one particular cancer (this could be good or bad) and this strategy could fire back as this is capital and time intensive.

Considering all 4 platforms IMU's of drugs and trail stages of Ph1 and Ph2, TLX, RAC and IMM are far ahead comapared to IMU and the market is trusting these companies and recent capital raise and their SP support what market believes. LC may be really good subject matter expert and recent individual treatment case needs to supported by new data but she is loosing credibility as leader of the company (sometimes I feel she had a big mouth and can't understand what she wanted to communicate to the market rather than repeating same rant for several years and asking money in the market). The only way, she can prove that IMU science is working is with p-values and statistically significant data. I understand that she has borrowed a lot of money to buy IMU shares and haven't sold a single shares (that's confidence and trust) however this market needs data and needs sooner than later.

DYOR before buy and sell, I'm not at state where selling market any sense. As many investors, sinking share price is not a good feeling for anyone except shorters and they are the only one making money here and they do not care whether IMU will be successful or not. I understand anything below 5.8C would be buy but will wait to see where the SP is heading

	ATX	Amplia Therapeutics	Treatment
1	BDX	BCAL Diagnostics	Diagnostics
2	CHM	Chimeric Therapeutics	Treatment
3	COV	Cleo Diagnostics	Diagnostics
4	CYC	Cyclopharm	Diagnostics
5	GTG	Genetic Technologies	Diagnostics
6	IIQ	Inoviq	Treatment & Diagnostics
7	IMM	Imutep	Treatment
8	IMU	Imugene	Treatment
9	IVX	Invion	Treatment
10	KAZ	Kazia Therapeutics	Treatment
11	NOX	Noxopharm	Treatment
12	OSL	OncoSil Medical	Treatment
13	PAB	Patrys	Treatment
14	PTX	Prescient Therapeutics	Treatment
15	PYC	PYC Therapeutics	Treatment
16	RAC	Race Oncology	Treatment
17	RAD	Radiopharm Theranostics	Treatment & Diagnostics
18	RHY	Rhythm Biosciencs	Diagnostics
19	TLX	Telix Pharmaceuticals	Treatment & Diagnostics
20	VHT	Volpara Health Techbnologies	Diagnostics